We are live on
!
Find out more
Atara Biotherapeutics
ATRA
ATRA
84 hedge funds and large institutions have $508M invested in Atara Biotherapeutics in 2015 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 18 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
89% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 18
7% less funds holding
Funds holding: 90 → 84 (-6)
17% less capital invested
Capital invested by funds: $612M → $508M (-$104M)
26% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 23
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
65% less call options, than puts
Call options by funds: $472K | Put options by funds: $1.35M
Holders
84
Holders Change
-6
Holders Change %
-6.67%
% of All Funds
2.2%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
17
Increased
34
Reduced
18
Closed
23
Calls
$472K
Puts
$1.35M
Net Calls
-$882K
Net Calls Change
-$1.05M
Top Buyers
Top Sellers
| 1 |
Jennison Associates
New York
|
-$26.5M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$25.3M |
| 3 |
BAMCO Inc
New York
|
-$24.1M |
| 4 |
State Street
Boston,
Massachusetts
|
-$5.2M |
| 5 |
JP Morgan Chase
New York
|
-$3.49M |
